Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
105.20 EUR | +0.63% | +0.32% | +17.20% |
10:08am | SANOFI : Oddo BHF raises its target price on the stock | CF |
09:02am | SANOFI : Gradually proving it is right |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 36.13B | 36.04B | 37.76B | 43B | 43.07B | |||||
Other Revenues, Total | 1.5B | 1.33B | 1.41B | 2.39B | 2.96B | |||||
Total Revenues | 37.63B | 37.37B | 39.18B | 45.39B | 46.03B | |||||
Cost of Goods Sold, Total | 11.97B | 12.1B | 12.25B | 13.69B | 14.22B | |||||
Gross Profit | 25.66B | 25.26B | 26.92B | 31.7B | 31.82B | |||||
Selling General & Admin Expenses, Total | 9.97B | 9.45B | 9.6B | 10.54B | 10.76B | |||||
R&D Expenses | 6.02B | 5.53B | 5.69B | 6.71B | 6.73B | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 2.15B | 1.68B | 1.58B | 1.83B | 2.17B | |||||
Other Operating Expenses | 678M | 997M | 1.48B | 1.59B | 2.95B | |||||
Other Operating Expenses, Total | 18.81B | 17.66B | 18.35B | 20.66B | 22.62B | |||||
Operating Income | 6.85B | 7.61B | 8.58B | 11.04B | 9.2B | |||||
Interest Expense, Total | -544M | -459M | -362M | -394M | -527M | |||||
Interest And Investment Income | 91M | 37M | 3M | 173M | 546M | |||||
Net Interest Expenses | -453M | -422M | -359M | -221M | 19M | |||||
Income (Loss) On Equity Invest. | 255M | 359M | 39M | 68M | -115M | |||||
Currency Exchange Gains (Loss) | 1M | -6M | 2M | -4M | -2M | |||||
Other Non Operating Income (Expenses) | 236M | 144M | 70M | 37M | -665M | |||||
EBT, Excl. Unusual Items | 6.88B | 7.68B | 8.33B | 10.92B | 8.44B | |||||
Restructuring Charges | -1.06B | -1.06B | -820M | -1.34B | -1.49B | |||||
Merger & Related Restructuring Charges | -3M | -82M | -17M | -3M | -20M | |||||
Gain (Loss) On Sale Of Investments | - | 7.39B | 3M | 1M | -1M | |||||
Gain (Loss) On Sale Of Assets | 296M | 443M | 418M | 655M | 688M | |||||
Asset Writedown | -3.6B | -330M | -192M | 228M | -896M | |||||
Legal Settlements | 327M | - | - | - | - | |||||
Other Unusual Items | 238M | 124M | 115M | 27M | 318M | |||||
EBT, Incl. Unusual Items | 3.08B | 14.16B | 7.84B | 10.49B | 7.04B | |||||
Income Tax Expense | 139M | 1.81B | 1.56B | 2.01B | 1.6B | |||||
Earnings From Continuing Operations | 2.94B | 12.35B | 6.28B | 8.48B | 5.44B | |||||
Earnings Of Discontinued Operations | -101M | - | - | - | - | |||||
Net Income to Company | 2.84B | 12.35B | 6.28B | 8.48B | 5.44B | |||||
Minority Interest | -31M | -36M | -56M | -113M | -36M | |||||
Net Income - (IS) | 2.81B | 12.31B | 6.22B | 8.37B | 5.4B | |||||
Net Income to Common Incl Extra Items | 2.81B | 12.31B | 6.22B | 8.37B | 5.4B | |||||
Net Income to Common Excl. Extra Items | 2.91B | 12.31B | 6.22B | 8.37B | 5.4B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 2.24 | 9.82 | 4.97 | 6.69 | 4.31 | |||||
Basic EPS - Continuing Operations | 2.33 | 9.82 | 4.97 | 6.69 | 4.31 | |||||
Basic Weighted Average Shares Outstanding | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B | |||||
Net EPS - Diluted | 2.23 | 9.77 | 4.95 | 6.66 | 4.3 | |||||
Diluted EPS - Continuing Operations | 2.31 | 9.77 | 4.95 | 6.66 | 4.3 | |||||
Diluted Weighted Average Shares Outstanding | 1.26B | 1.26B | 1.26B | 1.26B | 1.26B | |||||
Normalized Basic EPS | 3.42 | 3.8 | 4.11 | 5.36 | 4.19 | |||||
Normalized Diluted EPS | 3.4 | 3.78 | 4.09 | 5.34 | 4.17 | |||||
Dividend Per Share | 3.15 | 3.2 | 3.33 | 3.56 | 3.76 | |||||
Payout Ratio | 136.64 | 31.97 | 64.41 | 49.79 | 82.48 | |||||
American Depositary Receipts Ratio (ADR) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |||||
Supplemental Items | ||||||||||
EBITDA | 10.16B | 10.5B | 11.26B | 14.06B | 12.52B | |||||
EBITA | 9.01B | 9.32B | 10.2B | 12.91B | 11.43B | |||||
EBIT | 6.85B | 7.61B | 8.58B | 11.04B | 9.2B | |||||
EBITDAR | 10.21B | 10.52B | 11.29B | 14.09B | 12.54B | |||||
Effective Tax Rate - (Ratio) | 4.52 | 12.8 | 19.88 | 19.12 | 22.76 | |||||
Total Current Taxes | 1.89B | 1.91B | 1.91B | 2.77B | 2.56B | |||||
Total Deferred Taxes | -1.75B | -99M | -350M | -768M | -958M | |||||
Normalized Net Income | 4.27B | 4.77B | 5.15B | 6.71B | 5.24B | |||||
Interest Capitalized | 14M | 11M | 14M | 17M | 26M | |||||
Interest on Long-Term Debt | 53M | 49M | 49M | 57M | 65M | |||||
Non-Cash Pension Expense | -111M | -142M | 49M | -25M | 50M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 6.87B | 5.86B | 5.69B | 6.71B | 6.73B | |||||
Net Rental Expense, Total | 50M | 27M | 25M | 26M | 19M | |||||
Imputed Operating Lease Interest Expense | 8.83M | 4.09M | 3.26M | 3.92M | 4.24M | |||||
Imputed Operating Lease Depreciation | 41.17M | 22.91M | 21.74M | 22.08M | 14.76M | |||||
Stock-Based Comp., Other (Total) | 252M | 274M | 244M | 245M | 283M | |||||
Total Stock-Based Compensation | 252M | 274M | 244M | 245M | 283M |